期刊文献+

阿替普酶溶栓治疗急性缺血性脑卒中效果观察 预览

Observation on the effect of ateplase thrombolysis in the treatment of acute ischemic stroke
在线阅读 下载PDF
收藏 分享 导出
摘要 目的观察急性缺血性脑卒中(AIS)患者采用阿替普酶溶栓治疗的效果。方法选择2017年4月~2018年8月收治的50例AIS患者,分为甲、乙两组,分别给予常规治疗与阿替普酶溶栓治疗,对比两组疗效。结果甲、乙组治疗总有效率分别为96.0%,差异有统计学意义(P<0.05);治疗后,乙组NHISS、改良RANKIN量表水平低于甲组,SOD高于甲组,差异有统计学意义(P<0.05);两组患者不良反应发生率经比较,差异无统计学意义(P>0.05)。结论阿替普酶溶栓用于AIS临床治疗,疗效确切,过程相对安全可靠。 Objective To observe the effect of artemisinin thrombolytic therapy in patients with acute ischemic stroke( AIS). Methods 50 patients with AIS admitted from April 2017 to August 2018 were divided into two groups: group A and group B. They were treated with routine therapy and ateplase thrombolysis respectively,and the curative effect was compared between the two groups. Results The total effective rates of group A and B were 96.0% and the difference was significant( P < 0.05). After treatment,the levels of NHISS and modified RANKIN scale in group B were significantly lower than those in group A,and SOD was significantly higher than that in group A( P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups( P > 0.05). Conclusion Atyplase thrombolytic therapy for AIS is effective,safe and reliable,and worthy of promotion.
作者 邱玲 QIU Ling(Department of neurology,the first hospital of Wuhan,Wuhan 430000,China)
出处 《中国处方药》 2019年第10期103-104,共2页 Journal of China Prescription Drug
关键词 缺血性脑卒中 阿替普酶 溶栓 效果观察 Ischemic stroke Ateplase Thrombolysis Effect observation
  • 相关文献

二级参考文献23

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈